Categories: News

New Multicenter Study Demonstrates SyMRI’s Potential to Transform Clinical Neuroimaging Workflows

LINKÖPING, Sweden, June 3, 2025 /PRNewswire/ — SyntheticMR AB (publ) is proud to share the results of a newly published multicenter clinical study in the American Journal of Neuroradiology (AJNR), demonstrating the diagnostic equivalence—and potential advantages—of SyMRI® using the 3D-QALAS method compared to conventional 3D MRI in routine clinical neuroimaging. 

The peer-reviewed study, available here, evaluated a large and diverse patient population across multiple imaging centers. The findings confirmed that 3D synthetic MRI using SyMRI matched conventional MRI in sensitivity, specificity, and diagnostic accuracy. Notably, SyMRI received even higher ratings for image quality. 

“These results underscore the value of SyMRI in real-world clinical practice,” said Johanna Norén, Acting CEO of SyntheticMR. “With diagnostic performance on par with conventional imaging—and with added benefits in workflow efficiency and quantitative imaging—SyMRI has the potential to enhance diagnostic confidence while streamlining MRI protocols.” 

The study highlights SyMRI’s ability—particularly in 3D—to deliver quantitative, multi-contrast images in a single, fast scan without compromising image quality, making it a strong candidate for advancing scalable and standardized neuroimaging practices. 

This clinical evidence further strengthens SyntheticMR’s mission to redefine MRI efficiency, bringing the power of objective, quantitative imaging into routine clinical use. 

For additional information, please contact Johanna Noren, acting CEO, SyntheticMR AB, johanna.noren@syntheticmr.com; +46 70 619 21 00 

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/syntheticmr-ab/r/new-multicenter-study-demonstrates-symri-s-potential-to-transform-clinical-neuroimaging-workflows,c4158230

The following files are available for download:

 

View original content:https://www.prnewswire.com/news-releases/new-multicenter-study-demonstrates-symris-potential-to-transform-clinical-neuroimaging-workflows-302471723.html

SOURCE SyntheticMR AB

Staff

Recent Posts

TODAY SHOW EXPOSES AI MEDICAL SCAMS TARGETING LIPEDEMA PATIENTS

LOS ANGELES, Dec. 5, 2025 /PRNewswire/ -- AI-generated deepfake scams are rapidly spreading across social media,…

2 hours ago

Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc.

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / December 5, 2025…

5 hours ago

Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc.

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / December 5, 2025…

5 hours ago

Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink:…

8 hours ago

Techficient Launches Surefire, Its Proprietary Modern Underwriting Engine

BOISE, Idaho, Dec. 5, 2025 /PRNewswire/ -- Techficient, a leading innovator in Insurtech solutions, announces the…

8 hours ago

Clinical Education Alliance Becomes Decera Clinical, Delivering Education, Insights, and Communications

Company brings its Scientific Activation™ mission to life at ASH Annual Meeting following November rebrand RESTON,…

8 hours ago